BIOREM Inc.
BIRMF
$1.49
$0.04363.01%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.76% | -24.91% | -25.83% | 165.70% | 67.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.76% | -24.91% | -25.83% | 165.70% | 67.45% |
| Cost of Revenue | 20.59% | -17.81% | -3.83% | 144.65% | 66.55% |
| Gross Profit | 52.18% | -41.42% | -64.77% | 219.78% | 70.63% |
| SG&A Expenses | 29.14% | -20.17% | -7.31% | 147.62% | 32.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.00% | -18.33% | -4.93% | 144.97% | 59.96% |
| Operating Income | 103.87% | -87.76% | -89.20% | 297.32% | 340.66% |
| Income Before Tax | 116.75% | -89.79% | -92.21% | 328.51% | 445.85% |
| Income Tax Expenses | 116.87% | -89.63% | -89.90% | 328.62% | 445.56% |
| Earnings from Continuing Operations | 116.79% | -89.85% | -92.87% | 328.47% | 445.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 116.79% | -89.85% | -92.87% | 328.47% | 445.82% |
| EBIT | 103.87% | -87.76% | -89.20% | 297.32% | 340.66% |
| EBITDA | 96.35% | -69.28% | -86.98% | 295.77% | 240.68% |
| EPS Basic | 112.66% | -91.41% | -92.81% | 325.52% | 443.48% |
| Normalized Basic EPS | 111.85% | -91.30% | -92.19% | 326.11% | 446.15% |
| EPS Diluted | 118.94% | -90.07% | -117.34% | 286.16% | 386.96% |
| Normalized Diluted EPS | 115.79% | -89.92% | -91.64% | 302.75% | 392.31% |
| Average Basic Shares Outstanding | 2.12% | 18.80% | -0.64% | 0.65% | 0.00% |
| Average Diluted Shares Outstanding | 0.44% | 2.60% | -7.26% | 6.52% | 18.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |